Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cirtran (CIRX) Shares Outstanding (Weighted Average) (2017 - 2025)

Historic Shares Outstanding (Weighted Average) for Cirtran (CIRX) over the last 14 years, with Q3 2025 value amounting to $4.9 million.

  • Cirtran's Shares Outstanding (Weighted Average) changed 0.0% to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $4.9 million for FY2024, which is 0.0% changed from last year.
  • Per Cirtran's latest filing, its Shares Outstanding (Weighted Average) stood at $4.9 million for Q3 2025, which was down 0.0% from $4.9 million recorded in Q2 2025.
  • Cirtran's 5-year Shares Outstanding (Weighted Average) high stood at $4.9 million for Q2 2021, and its period low was $4.7 million during Q1 2021.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $4.9 million (2021), whereas its average is $4.9 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first soared by 988.8% in 2021, then changed by 0.0% in 2022.
  • Over the past 5 years, Cirtran's Shares Outstanding (Weighted Average) (Quarter) stood at $4.9 million in 2021, then rose by 1.11% to $4.9 million in 2022, then changed by 0.0% to $4.9 million in 2023, then changed by 0.0% to $4.9 million in 2024, then changed by 0.0% to $4.9 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $4.9 million in Q3 2025, compared to $4.9 million in Q2 2025 and $4.9 million in Q1 2025.